dactinomycin

dactinomycin (DACTINOMYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

DACTINOMYCIN is a marketed brand name for dactinomycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

dactinomycin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.